Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
Farr (1989) Approved Drugs for Off-Label (Unlabeled) Indications Ramon v. Farr
reasonable safeguards
recalls
red flags
refill reminder exception
refills authorization of long-term care facilities schedule III, IV, and V substances authorization of dispensing of prescriptions multiple refills written on same day
registration, CSA denial, revocation, or suspension distribution manufacturing research with controlled substance applications for dispensing exemptions modification, transfer, or termination separate registrations
registration number, DEA
regulation for outcomes of prescription drug samples State Regulation of Third-Party Plans approaches of managed care plan formularies reasons for
reimportation of drugs
See risk evaluation and mitigation strategies (REMS) Drug Price Competition and Patent Term Restoration Act of 1984 Historical Overview of the Federal Food, Drug, and Cosmetic Act Preface Purpose of a Controlled Substance Prescription The Road to an Approved New Drug Application Bibliography Food and Drug Administration Amendments Act of 2007 New Drug Approval Prescription Drug Labeling Information for the Patient See risk evaluation and mitigation strategies (REMS) Useful Written Patient Information and Medication Guides
Renacidin
repackaging drugs Food, Drug, and Cosmetic Act offenses adulteration regulations manufacturing, defined
reregistration, applications for
radiopharmaceuticals
rebates
recordkeeping
red yeast rice
reimbursement for drugs
research, with controlled substance
Res ipsa loquitur
retail community pharmacy
retrospective review, drug use review
Riegel v. Medtronic, Inc. (2008)
right-to-try laws
risk evaluation and mitigation strategies (REMS) FDA Safety and Innovation Act of 2012 Drug Information Website for Consumers and Health Professionals: Drugs@FDA The Road to an Approved New Drug Application
risk management continuous quality improvement programs institutional controls malpractice overview pharmacist as risk manager rules for Continuous Quality Improvement Programs as Risk Management malpractice insurance overview problems and pitfalls of strategies
Rite Aid
Rite Aid of New Jersey, Inc. v. Board of Pharmacy (1973)
Robinson-Patman Act (1936) aftermath of portland decision competing buyers and injury to competition Nonprofit Institutions Act “own use” doctrine brand-name prescription drugs antitrust litigation meeting competition defense The Robinson-Patman Act